étude était renseigné pour 114 patients (pas d'équivalence de niveau d'études ou ne souhaitant pas répondre pour 30 patients). 8 patients avaient terminé le niveau primaire (5,5% des patients 14 un niveau professionnel : diplôme professionnel type, 17 le niveau collège, pp.42-75 ,
Causes of death among persons reported with AIDS., American Journal of Public Health, vol.83, issue.10, pp.1429-1461, 1993. ,
DOI : 10.2105/AJPH.83.10.1429
AZT 5'-Phosphonates: Achievements and Trends in the Treatment and Prevention of HIV Infection, Acta Naturae, vol.5, issue.3, pp.54-61, 2013. ,
Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population, JAMA, vol.300, issue.1, pp.51-60, 2008. ,
DOI : 10.1001/jama.300.1.51
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population, J Acquir Immune Defic Syndr, vol.46, issue.1, pp.72-79, 1999. ,
URL : https://hal.archives-ouvertes.fr/inserm-00170726
Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries, Int J Epidemiol. déc, vol.38, issue.6, pp.1624-1657, 2009. ,
Decouvertes de séropositivité VIH et SIDA . Point épidémiologique. [Internet]. 2016 [cité 3 sept 2016]. Disponible sur: http://invs.santepubliquefrance.fr/fr, 124392. ,
Population-based HIV-1 incidence in France, 2003?08: a modelling analysis, Lancet Infect Dis. oct, vol.10, issue.10, pp.682-689, 2010. ,
Bulletin des réseaux de surveillance des infections sexuellement transmissibles Rénago, Renachla et ResIST, Disponible sur, 2017. ,
Prise en charge médicale des personnes vivant avec le VIH, recommandations du groupe d'experts: rapport 2013 sous la direction du Pr Philippe Morlat et sous l'égide du CNS et de l'ANRS. La Documentation Française, 2013. ,
La consommation de tabac en France en 2014: caractéristiques et évolutions récentes, Evolutions. janv, issue.31, pp.1-6, 2015. ,
La consommation d'alcool en France en 2014, avrilEvolutions, issue.32, pp.1-6, 2015. ,
The spectrum of malignancies in HIV-infected patients in 2006 in France: The ONCOVIH study, International Journal of Cancer, vol.45, issue.2, pp.467-75, 2011. ,
DOI : 10.1086/518606
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study, The Lancet Oncology, vol.10, issue.12, pp.1152-1161, 2009. ,
DOI : 10.1016/S1470-2045(09)70282-7
Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population, AIDS, vol.24, issue.8, pp.1228-1258, 2010. ,
DOI : 10.1097/QAD.0b013e328339192f
Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus???Infected Patients<subtitle>A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4</subtitle><alt-title>Antiretroviral Drugs, Risk of MI, and HIV</alt-title>, Archives of Internal Medicine, vol.170, issue.14, pp.1228-1266, 2010. ,
DOI : 10.1001/archinternmed.2010.197
Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy, Kidney International, vol.80, issue.3, pp.302-311, 2011. ,
DOI : 10.1038/ki.2011.124
Causes de décès des personnes séropositives pour le VIH en succès immunovirologique en, 2010. ,
Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sex Health, pp.547-55, 2012. ,
Incidence of HIV-Related Anal Cancer Remains Increased Despite Long-Term Combined Antiretroviral Treatment: Results From the French Hospital Database on HIV, Journal of Clinical Oncology, vol.30, issue.35, pp.4360-4366, 2012. ,
DOI : 10.1200/JCO.2012.44.5486
Risk of Human Papillomavirus???Associated Cancers Among Persons With AIDS, JNCI: Journal of the National Cancer Institute, vol.101, issue.16, pp.1120-1150, 2009. ,
DOI : 10.1093/jnci/djp205
Multifactorial nature of human immunodeficiency virus disease: implications for therapy, Science, vol.262, issue.5136, pp.1011-1019, 1993. ,
DOI : 10.1126/science.8235617
Immunopathogenic Mechanisms of HIV Infection, Annals of Internal Medicine, vol.124, issue.7, pp.654-63, 1996. ,
DOI : 10.7326/0003-4819-124-7-199604010-00006
Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection, New England Journal of Medicine, vol.332, issue.4, pp.201-209, 1995. ,
DOI : 10.1056/NEJM199501263320401
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation, Nature Medicine, vol.41, issue.2, pp.208-222, 1998. ,
DOI : 10.1016/0022-1759(89)90260-3
Acute cytomegalovirus infection in AIDS patients with CD4 counts above 100 x 10(6) cells/l following combination antiretroviral therapy including protease inhibitors, AIDS Lond Engl. nov, vol.11, issue.13, pp.1659-60, 1997. ,
Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. The Lancet, janv, vol.353, issue.9148, pp.201-204, 1999. ,
Bacterial Pneumonia in Persons Infected with the Human Immunodeficiency Virus, New England Journal of Medicine, vol.333, issue.13, pp.845-51, 1995. ,
DOI : 10.1056/NEJM199509283331305
Etat de santé de la population vivant avec le VIH en France en 2011 et caractéristiques des personnes récemment diagnostiquées ,
Serogroup W in Man Who Has Sex with Men, Japan, Emerging Infectious Diseases, vol.20, issue.9, p.1585, 2014. ,
DOI : 10.3201/eid2009.140349
Situation socioéconomique des personnes vivant avec le VIH suivies à l'hôpital en France métropolitaine en 2011. Premiers résultats de l'enquête ANRS-Vespa2, Bull Epidémiol Hebd, issue.26?27, pp.293-302, 2013. ,
The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research, Infectious Agents and Cancer, vol.5, issue.1, p.8, 2010. ,
DOI : 10.1186/1750-9378-5-8
Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals, Vaccine, vol.20, issue.5-6, pp.905-913, 2001. ,
DOI : 10.1016/S0264-410X(01)00383-8
Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children, Vaccine, vol.23, issue.48-49, pp.5517-5542, 2005. ,
DOI : 10.1016/j.vaccine.2005.07.038
Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults, Vaccine, vol.30, issue.37, pp.5482-5488, 2012. ,
DOI : 10.1016/j.vaccine.2012.06.069
Response to Measles, Mumps, and Rubella Revaccination in HIV-Infected Children with Immune Recovery after Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.45, issue.5, pp.637-679, 2007. ,
DOI : 10.1086/520651
Immune response to hepatitis a vaccination in HIV-infected men in Greece, International Journal of STD & AIDS, vol.3, issue.1, pp.464-471, 2012. ,
DOI : 10.2217/hiv.09.39
Efectos de la vacunaci??n antigripal sobre el porcentaje de linfocitos T CD4 positivos en pacientes VIH 1/2 positivos: estudio de una cohorte, Gaceta Sanitaria, vol.23, issue.4, pp.315-336, 2009. ,
DOI : 10.1016/j.gaceta.2008.10.011
Comparison of the effects of acute Influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts, Journal of Clinical Virology, vol.26, issue.3, pp.307-322, 2003. ,
DOI : 10.1016/S1386-6532(02)00047-1
Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women, Vaccine, vol.22, issue.27-28, pp.3707-3719, 2004. ,
DOI : 10.1016/j.vaccine.2004.03.023
Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods, HIV Medicine, vol.162, issue.4, pp.203-210, 2008. ,
DOI : 10.1086/314890
URL : https://hal.archives-ouvertes.fr/hal-00428147
Pneumococcal Disease among Human Immunodeficiency Virus-Infected Persons: Incidence, Risk Factors, and Impact of Vaccination, Clinical Infectious Diseases, vol.32, issue.5, pp.794-800, 2001. ,
DOI : 10.1086/319218
Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease, HIV Medicine, vol.10, issue.8, pp.488-95, 2009. ,
DOI : 10.1111/j.1468-1293.2009.00717.x
Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults, Vaccine, vol.19, issue.7-8, pp.886-894, 2000. ,
DOI : 10.1016/S0264-410X(00)00232-2
A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection, New England Journal of Medicine, vol.349, issue.14, pp.1341-1349, 2003. ,
DOI : 10.1056/NEJMoa035060
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine, Journal of Infectious Diseases, vol.212, issue.1, pp.18-27, 2015. ,
DOI : 10.1093/infdis/jiu631
Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus, The Journal of Pediatrics, vol.161, issue.4, pp.676-681, 2012. ,
DOI : 10.1016/j.jpeds.2012.04.005
Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in 2- to 10-year-old Human Immunodeficiency Virus-infected Children, 47?52. 51. HCSP. Vaccination contre les infections invasives à méningocoque C au-delà de 24 ans, notamment chez les hommes ayant des relations sexuelles avec d'autres hommes (HSH) [Internet]. Paris: Haut Conseil de la Santé Publique; 2014 nov, 2012. ,
DOI : 10.1097/INF.0b013e318236c67b
Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART, Vaccine, vol.27, issue.50, pp.7059-64, 2009. ,
DOI : 10.1016/j.vaccine.2009.09.063
Vaccine-Associated Measles Pneumonitis in an Adult with AIDS, Annals of Internal Medicine, vol.129, issue.2, pp.104-110, 1998. ,
DOI : 10.7326/0003-4819-129-2-199807150-00007
Excess Mortality Due to Pneumonia or Influenza During Influenza Seasons Among Persons With Acquired Immunodeficiency Syndrome, Archives of Internal Medicine, vol.161, issue.3, pp.441-447, 2001. ,
DOI : 10.1001/archinte.161.3.441
Cardiopulmonary Hospitalizations During Influenza Season in Adults and Adolescents With Advanced HIV Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.34, issue.3, pp.304-311, 1999. ,
DOI : 10.1097/00126334-200311010-00008
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses, The Lancet Infectious Diseases, vol.9, issue.8, pp.493-504, 2009. ,
DOI : 10.1016/S1473-3099(09)70175-6
Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis, HIV Medicine, vol.3, issue.1, pp.57-61, 2008. ,
DOI : 10.7326/0003-4819-131-6-199909210-00006
Efficacy of Influenza Vaccination in HIV-Infected Persons, Annals of Internal Medicine, vol.131, issue.6, pp.430-433, 1999. ,
DOI : 10.7326/0003-4819-131-6-199909210-00006
Comparison of the effects of acute Influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts, Journal of Clinical Virology, vol.26, issue.3, pp.307-322, 2003. ,
DOI : 10.1016/S1386-6532(02)00047-1
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France ?: Hepatitis B prevalence in the HOPS, the HIV Outpatient Study (HOPS) Investigators. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, pp.879-86, 1996. ,
Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: The EPIB 2008 study, Journal of Hepatology, vol.53, issue.6, pp.1006-1018, 2010. ,
DOI : 10.1016/j.jhep.2010.04.041
High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients, Hepatology, vol.18, issue.3, pp.912-934, 2013. ,
DOI : 10.1111/j.1365-2893.2010.01321.x
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV, AIDS, vol.20, issue.3, pp.419-446, 2006. ,
DOI : 10.1097/01.aids.0000200537.86984.0e
Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults, Vaccine, vol.30, issue.41, pp.5973-5980, 2012. ,
DOI : 10.1016/j.vaccine.2012.07.028
Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard ose vaccination: a metaanalysis, Int J STD AIDS. févr, vol.24, issue.2, pp.177-199, 2013. ,
Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons, International Journal of STD & AIDS, vol.31, issue.1, pp.201-207, 2014. ,
DOI : 10.1016/j.vaccine.2012.12.047
Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCVcoinfected patients, and factors associated with HAV and HBV vaccination, Vaccine. 3 nov, vol.29, issue.47, pp.8656-60, 2011. ,
Insuffisance de couverture vaccinale d???une cohorte fran??aise de patients s??ropositifs VIH, M??decine et Maladies Infectieuses, vol.40, issue.12, pp.683-90, 2010. ,
DOI : 10.1016/j.medmal.2010.06.005
Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.3, pp.272-277, 1999. ,
DOI : 10.1097/QAI.0b013e318183a9c0
Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men, Hepatology, vol.57, issue.5, pp.1734-1775, 2013. ,
DOI : 10.1097/QAI.0b013e31821fdec3
Fulminant VZV infection in an adult AIDS patient treated with steroids: A case report, Journal of Clinical Virology, vol.60, issue.1, pp.63-69, 2014. ,
DOI : 10.1016/j.jcv.2014.02.008
Seroprevalence of Varicella in the French Population, The Pediatric Infectious Disease Journal, vol.25, issue.1, pp.41-45, 2006. ,
DOI : 10.1097/01.inf.0000195636.43584.bb
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia, 1576?85. 75. HCSP. Recommandations vaccinales contre les infections à papillomavirus humains chez les hommes [Internet] Disponible sur, 2011. ,
DOI : 10.1056/NEJMoa1010971
Prévalence de l'infection par le VIH et le virus de l'hépatite C chez les personnes détenues en France. Résultats de l'enquête Prévacar 2010, 35?36):445?50. 77. HIV causal collaboration. When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries: An Observational Study, p.509, 2011. ,
Prévalence des co-infections par les virus des hépatites B et C dans la population VIH, France, juin, BEH BEH. Juin, vol.23, issue.23, pp.109-112109, 2004. ,
La couverture vaccinale diphtérie, tétanos, poliomyélite chez l'adulte en France: résultats de l'enquête Santé et Protection sociale, Bull Epidemiol Hebd, vol.441, issue.5, pp.51-53, 2002. ,
Maladies infectieuses / Dossiers thématiques / Accueil [Internet] Disponible sur: http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies- infectieuses/Maladies-a-prevention-vaccinale/Couverture- vaccinale, 2017. ,
Couverture vaccinale contre le grippe saisonnière dans les groupes cibles et mesure de l'efficacité vaccinale. Couverture vaccinale par les vaccins diphtérietétanos-poliomyélite (dTP) et antipneumococcique chez les personnes âgées de 65 ans et plus, 2011. ,
Evaluation auprès des parents du carnet de santé n°CERFA 12593*01 (modèle en vigueur depuis le 1er janvier 2006) Evaluation réalisée pour la DGS, Disponible sur, p.2012, 2016. ,
Couverture vaccinale des enfants et des adolescents en France: résultats des enquêtes menées en milieu scolaire, Bull Epidemiol Hebd, vol.6, pp.45-54, 2001. ,
Couverture vaccinale des soignants travaillant dans les établissements de soins de France. Résultats de l'enquête nationale Vaxisoin, Bull Epidemiol Hebd. 09, issue.35?36, pp.371-377, 2009. ,
Disponible sur: http://invs.santepubliquefrance.fr/Dossiers- thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Couverture- vaccinale, Maladies infectieuses / Dossiers thématiques / Accueil [Internet], 2016. ,
Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey, BMC Public Health, vol.10, issue.42, 2011. ,
DOI : 10.1186/1471-2458-10-159
Disponible sur: http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies- infectieuses/Maladies-a-prevention-vaccinale, Maladies infectieuses / Dossiers thématiques / Accueil [Internet], 2017. ,
Estimation des couvertures vaccinales à 24 mois à partir des certificats de santé du 24eme mois, 2004. ,
Vaccinations: attitudes et pratiques des médecins généralistes, Etudes Result. mars, issue.910, pp.1-8, 2015. ,
Opinion des médecins généralistes de la région Provence-Alpes-Côte d'Azur sur le régime obligatoire ou recommandé des vaccins en population générale, BEH. juillet, issue.24?25, pp.406-419, 2015. ,
Tensions d'approvisionnement - ANSM : Agence nationale de sécurité du médicament et des produits de santé [Internet] Disponible sur: http://ansm.sante.fr/S- informer/Informations-de-securite-Ruptures-de-stock-des-medicaments/Vaccins- combines-contenant-la-Valence-Coqueluche-Tensions-d-approvisionnement, 2017. ,
The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey, EBioMedicine, vol.12, pp.295-301, 2016. ,
DOI : 10.1016/j.ebiom.2016.08.042
General practitioners??? attitudes and behaviors toward HPV vaccination: A French national survey, Vaccine, vol.34, issue.6, pp.762-770, 2016. ,
DOI : 10.1016/j.vaccine.2015.12.054
Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France, EBioMedicine, vol.2, issue.8, pp.891-898, 2015. ,
DOI : 10.1016/j.ebiom.2015.06.018
Opening the ???Vaccine Hesitancy??? black box: how trust in institutions affects French GPs??? vaccination practices, Expert Review of Vaccines, vol.41, issue.347, pp.937-985, 2016. ,
DOI : 10.1057/9780230627611
URL : https://hal.archives-ouvertes.fr/hal-01452881
Etude qualitative sur la vaccination auprès du grand public et des professionnels de santé, Juin, 2016. ,
Baromètre santé INPES: des données complémentaires à celles des couvertures vaccinales. 9èmes journées de la prévention, 2014. ,